Grant & Eisenhofer named lead counsel in Quantum BioPharma suit
Quantum BioPharma said the U.S. District Court appointed Grant & Eisenhofer as lead counsel in a lawsuit alleging CIBC and RBC manipulated the company’s stock.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Quantum BioPharma said the U.S. District Court appointed Grant & Eisenhofer as lead counsel in a lawsuit alleging CIBC and RBC manipulated the company’s stock.